Strategic Partnerships DiaSorin has actively pursued collaborations and distributor relationships with major players (McKesson, Thermo Fisher Scientific, QIAGEN) to expand channel reach for Liaison NES and other immunodiagnostic offerings, presenting opportunities to align with your distribution and integration capabilities.

Precision Medicine Focus Recent leadership hires and expansions in precision medicine and companion diagnostics indicate a strategic emphasis on advanced, targeted testing, suggesting upsell potential for integrated automation and immunodiagnostic solutions that support precision workflows.

Automation and Tech DiaSorin emphasizes automation, integration, and workflow simplification in health systems and labs, signaling a readiness to partner on total laboratory automation, data analytics, and IT-enabled solutions leveraging their existing tech stack and platform capabilities.

Point-of-Care Growth With the Liaison NES rapid molecular POC system gaining distribution in U.S. hospital channels and FDA approvals, there are sales opportunities around expanding POC reach, clinical adoption, and companion diagnostics integration across hospital networks.

Global Expansion New international partnerships and CE-marked launches, including collaborations for TB and fungal diagnostics, indicate opportunities to propose global deployment, regulatory-ready kits, and cross-border support in multinational health systems.